✓ Reviewed by Ray Tao | Tooling Engineer ✓ Quality Review by Eddy Zhu | APQP / PPAP Coordinator

Tool & Process Validation Guide

Injection Molding Validation Procedure

Injection molding validation is the structured review used to determine whether the tool, molding process, measurement system and approval evidence are sufficient for the defined release scope. A successful trial sample alone does not prove that the mold or process is ready for controlled production or transfer.

A practical validation procedure should confirm that the active drawing revision is being used, critical-to-quality features can be measured credibly, trial results are representative of the intended process, and the required approval records are complete for the agreed customer or program scope.

The required depth of validation depends on the project. Some programs may use a focused dimensional and functional approval, while others may require additional measurement-system, capability, process-qualification or formal submission evidence defined by the customer.

Engineering definition: validation should prove readiness for a defined release condition. It should not be treated as a universal document package or as proof based only on one acceptable T1 sample.
Tool Condition Mold configuration, tooling condition, corrections and component status relevant to release.
Process Stability Whether the intended molding process can repeatedly produce the required part characteristics.
Measurement Credibility Whether the inspection method is suitable for the CTQs and the approval decision.
Approval Evidence Revision-controlled FAI, PPAP, capability or other records where required by the defined validation scope.

For typical submission contents and inspection records, see our FAI, CMM and PPAP-style quality documents .

Injection molding validation package with ballooned drawing FAI CMM data and controlled tool approval evidence
Validation should connect tool condition, process results, measurement credibility and controlled approval evidence.

Validation Framework

Four Things Injection Molding Validation Must Prove

A validation decision should not rely on a single dimensional report or one acceptable trial. The evidence should establish whether the tool condition, molding process, measurement method and approval records are suitable for the defined release scope.

01

Tool Condition

Validation should confirm that the physical mold configuration and relevant tooling components match the state being evaluated for release, transfer or further production trials.

What It Should Confirm

Current tool revision, component condition, documented modifications, applicable steel or heat-treatment records, mold setup status and unresolved tooling issues.

Typical Evidence

Mold change records, tooling inspection findings, trial history, supplier material records and heat-treatment documentation where relevant to the approved tooling specification.

Steel-selection boundary: steel certificates and heat-treatment records verify the supplied tooling condition, but they do not determine whether the original steel route was appropriate for the application. Review mold steel selection before tool release when cavity, core, inserts or wear components require different steel, hardness or localized insert strategies.
02

Process Stability

The molding process should be representative enough to support the intended approval decision, rather than producing acceptable parts only under an isolated or non-repeatable trial condition.

What It Should Confirm

The defined process can produce the required CTQs, fit, function or appearance characteristics with suitable repeatability for the agreed program scope.

Typical Evidence

Trial records, molding parameters, repeated sample results and, where required, process-window, capability or other customer-defined process-validation evidence.

03

Measurement Credibility

Validation evidence is only useful when the inspection method is suitable for the feature being measured and sufficiently reliable for the release decision.

What It Should Confirm

CTQs are linked to appropriate inspection methods, fixtures, datums and measurement conditions so that approval data can be interpreted consistently.

Typical Evidence

CMM or gauge records, calibration status, inspection instructions, fixtures and MSA or Gage R&R evidence where required by the customer or validation plan.

04

Approval Evidence

The final approval package should connect the physical tool state, inspected samples, released engineering data and any customer-required submission or deviation records.

What It Should Confirm

The approved result belongs to the correct drawing revision, tool configuration, resin condition, inspection scope and agreed release state.

Typical Evidence

FAI or dimensional-layout results, material records, approved deviations, revision-control documents and PPAP-style or other formal submissions where required by the customer.

Validation scope boundary: not every molding program requires the same evidence depth. Formal MSA, capability studies, PPAP, DOE or process qualification should be applied when required by the customer, CTQ risk, regulatory framework or agreed validation plan—not automatically to every mold.

For dimensional inspection methods, tooling checks and production quality controls, review our injection mold quality control and inspection methods .

Validation Scope

Validation Scope Changes with Program Risk and Release Objective

The required validation package should be scaled to the release objective, CTQ risk, customer requirements, regulatory context and transfer condition. Industry labels can provide context, but they do not by themselves determine which validation activities are mandatory.

Program Context 01

Standard Industrial / Commercial Programs

For programs with limited CTQs and no customer-defined formal submission requirement, validation may focus on dimensional, functional, visual and documented trial evidence appropriate to the agreed release scope.

Typical Evidence

Active drawing revision, dimensional or FAI results, material records, documented trial conditions, functional checks and approved deviations where applicable.

Additional Depth May Be Needed When

CTQs are sensitive, multiple cavities behave differently, assembly or cosmetic risks are significant, or the customer requests additional capability or process evidence.

Program Context 02

Automotive / Customer-Defined PPAP Programs

Automotive programs often require a more structured submission package, but the exact PPAP level, MSA scope, capability evidence and approval records should follow the customer-specific requirements for the project.

Typical Evidence

Ballooned drawing, dimensional results, control-plan records, material documentation, MSA or Gage R&R where required, capability evidence for designated characteristics and formal customer submission records.

Scope Boundary

PPAP level and statistical evidence should be defined by the customer, CTQ classification and launch requirement rather than assumed as identical for every automotive mold.

Program Context 03

Medical / Customer-Defined Validation Programs

Medical programs may require additional traceability, process qualification and change-control documentation when defined by the customer validation plan, product risk or applicable regulatory framework.

Typical Evidence

Material-lot traceability, documented process qualification, controlled inspection methods, revision records and IQ/OQ/PQ support where included in the agreed validation scope.

Scope Boundary

ISO 13485-style documentation, IQ/OQ/PQ or other medical validation records should be treated as customer- or program-defined requirements, not as universal requirements for every medical molding project.

Program Context 04

Export / Tool Transfer Programs

When a mold is being shipped, transferred to another molding site or handed over to the customer, validation should distinguish tool-transfer readiness from full production-process qualification at the receiving site.

Typical Evidence

Released tool configuration, mold setup information, trial records, inspection results, steel and heat-treatment records where applicable, spare-parts information and controlled handover documents.

Scope Boundary

Shipment approval does not automatically prove production capability at the receiving press, material lot, site or process condition. Additional validation may be required after transfer.

Define the Validation Scope Before Collecting Evidence

Before deciding whether FAI, MSA, PPAP, capability data, process qualification or revalidation is needed, define four inputs that control the depth of the validation plan.

Release Objective Sample approval, tool release, shipment, supplier handover or production release.
CTQ & Product Risk Dimensional, functional, cosmetic, safety or other critical characteristics.
Customer Requirements Required submission level, inspection evidence, traceability, capability or approval format.
Change / Transfer Context New tool, tool correction, resin change, process change, site transfer or revalidation event.
Compliance boundary: the program categories above are planning examples, not fixed validation rules. Final validation scope should follow the actual customer requirements, released engineering specification, agreed approval plan and applicable regulatory or quality-system obligations.

Validation Evidence

FAI vs PPAP vs MSA vs Capability: What Each Evidence Type Proves

These validation records are related, but they do not answer the same approval question. Use each method for the evidence it is designed to provide rather than treating FAI, PPAP, MSA and capability studies as interchangeable parts of one fixed validation package.

Sample Conformance vs Formal Approval

FAI and PPAP Answer Different Release Questions

First Article Inspection verifies whether identified sample parts conform to the active drawing and agreed inspection scope at a defined point in time. For some industrial programs, that may be sufficient for the agreed sample or tool-approval scope when no broader customer submission is required.

PPAP is a broader customer-defined production approval framework. It can connect dimensional results with material records, control plans, measurement evidence, capability data and other required submission documents for a defined production-release decision.

FAI Proves Sample conformity to the active drawing and agreed inspection method.
FAI Does Not Prove Long-term stability, cavity balance or future production capability by itself.
PPAP Proves Completion of the defined customer approval package and alignment of required production evidence.
PPAP Does Not Prove That future uncontrolled design, resin, tooling or process changes remain validated.
FAI and PPAP compared for injection molding validation sample conformance and formal production approval evidence
FAI supports sample-conformance evidence; PPAP can connect broader customer-required production approval records.
Gage R&R measurement system analysis supporting credible CTQ data before injection molding capability review
Measurement-system suitability should be established before capability data is relied upon for CTQ approval.
Measurement Credibility

MSA or Gage R&R Checks Whether the Data Can Be Trusted

A capability result is only meaningful when the inspection method is suitable for the characteristic being evaluated. Measurement review should consider feature geometry, plastic-part behavior, datum strategy, fixture design, operator influence and repeatability.

Formal MSA or Gage R&R may be required for designated CTQs, customer-controlled programs or capability studies, but it should not be presented as a universal requirement for every molded part.

Evidence sequence: establish measurement-system suitability first, then rely on that measurement data for capability or statistical release decisions where those studies are part of the validation plan.
Statistical Process Evidence

Capability Data Evaluates Defined CTQ Process Performance

Cpk, Ppk or other capability evidence is useful when the validation scope requires statistical evaluation of selected CTQ features under defined sampling, process and measurement conditions.

Capability should be interpreted in context. The result depends on the selected characteristic, sampling plan, measurement system, cavity strategy, process conditions and the stability of the data used for the calculation.

Useful For Customer-defined CTQs, launch evidence, multi-cavity review or other characteristics requiring statistical process evidence.
Does Not Replace Drawing revision control, cosmetic approval, functional testing, tooling condition review or customer sign-off.
Interpretation Boundary

A Single Trial Is Not a Capability Study

Acceptable dimensions from one T1 or T2 trial can support sample approval, but they do not by themselves establish statistically meaningful process capability. The evidence should be collected under conditions appropriate to the agreed validation objective.

Where capability analysis is required, review the selected CTQ, measurement method, sampling plan, process condition and cavity treatment before using the result as release evidence.

Validation Evidence Comparison Matrix

Use the matrix below to separate what each evidence type supports and what additional proof may still be required.

Evidence Type Primary Question What It Supports What It Does Not Prove Alone
FAI Do the inspected samples meet the released drawing and agreed inspection scope? Initial or sample-level dimensional conformity for the defined approval condition. Long-run repeatability, process capability or complete formal production approval.
PPAP Has the customer-defined production approval package been completed? Alignment of required part, process, material, inspection and submission evidence. Automatic validity after uncontrolled tool, design, material or process changes.
MSA / Gage R&R Is the measurement system suitable for the approval decision? Measurement repeatability, reproducibility or broader measurement-system credibility where required. Actual part conformity, mold condition or molding-process capability.
Capability Can the defined process produce selected CTQs within the agreed statistical evaluation framework? Statistical process evidence for selected characteristics under defined conditions. Full product approval, cosmetic acceptance, functional performance or future change control.
Process-qualification boundary: IQ/OQ/PQ or similar qualification frameworks are not interchangeable with FAI, PPAP, MSA or capability studies. They may be required when the customer validation plan, product risk or applicable regulatory framework calls for documented installation, operational or performance qualification.

Trial-to-Validation Sequence

What T1, T2 and Final Run-Off Should Prove Before Tool Release

Mold trials are not interchangeable approval events. Each stage should answer a different validation question—from initial risk discovery to correction verification and finally release evidence.

T1 Baseline

Initial Risk Discovery and Dimensional Baseline

T1 should establish an engineering baseline for the released part design under documented trial conditions. The objective is to identify major dimensional, cosmetic, fill, ejection, shutoff or assembly risks and determine which items require correction before later validation.

T1 data can support initial FAI or CTQ review, but it should not be treated automatically as proof of long-term process capability, final production stability or complete release readiness.

Typical Validation Evidence
  • Released drawing revision and cavity-identified samples
  • Initial FAI or CTQ dimensional baseline
  • Visible defect and functional issue records
  • Documented molding-condition sheet
  • Correction / steel-safe action list
T2 Verification

Correction Verification and Repeatability Review

T2 should verify whether the agreed corrections from the earlier trial improved the intended CTQs, appearance, assembly or tooling condition without introducing new issues elsewhere in the mold.

Depending on program scope, T2 can also provide stronger evidence on cavity-to-cavity consistency, repeated CTQ behavior, assembly fit and process repeatability. It still should not be assumed to prove full production capability unless the validation plan explicitly includes adequate statistical or process evidence.

Typical Validation Evidence
  • Correction closure linked to T1 findings
  • Re-measurement of affected CTQs
  • Cavity-to-cavity comparison where relevant
  • Assembly / function verification
  • Updated trial and revision records
Final Run-Off

Release Verification Under the Agreed Validation Scope

Final run-off should verify that the physical tool state, approved process conditions, inspected samples and controlled documentation all represent the condition being considered for shipment, handover or production release.

The required evidence may include final dimensional results, customer-defined PPAP elements, capability data, run-off records or other approval documents where those items are part of the agreed validation plan.

Typical Validation Evidence
  • Final tool and revision status
  • Representative approved samples
  • Final FAI / CMM records where required
  • Process or capability evidence where required
  • Controlled handover / release documentation
Stage boundary: T1, T2 and final run-off describe the role of each trial stage within the validation process. The exact sequence, naming, sample quantity, inspection scope and approval criteria should follow the actual project plan and customer requirements rather than a universal fixed template.
Need the detailed stage-by-stage trial checklist? Review the dedicated T0 T1 T2 mold trial guide and approval matrix for tool-function checks, dimensional baseline review, correction verification and pilot-stage evidence.

Process Validation Trigger

When Injection Molding Process Validation Is Actually Needed

Sample conformity and process validation answer different questions. Additional process evidence becomes useful when the release decision depends on showing that selected CTQs remain stable under defined production variation, rather than only confirming that sampled parts meet the drawing.

Trigger 01

CTQs Are Sensitive to Process Variation

Additional process evidence may be justified when important dimensions, sealing features, fit conditions or functional characteristics respond materially to changes in molding conditions.

Review Focus Identify which characteristics are process-sensitive and which controlled process inputs can influence their stability.

Trigger 02

Repeated or Multi-Cavity Results Show Meaningful Variation

When repeated trials or cavity-specific results vary meaningfully, sample inspection alone may not show whether the source is tooling, molding variation or the measurement system.

Review Focus Separate cavity effects, measurement variation and process variation before statistical evidence is relied upon.

Trigger 03

The Acceptable Operating Range Appears Narrow

Deeper process validation may be useful when acceptable results are obtained only within a limited operating region or when relatively small process changes materially affect selected CTQs.

Review Focus Determine whether the approved condition has sufficient operating margin for the intended production environment.

Trigger 04

The Defined Release Scope Requires Process Evidence

Some customer-controlled, launch-sensitive or regulated programs require documented process qualification, capability or other process evidence as part of the agreed approval plan.

Review Focus Follow the actual customer validation plan and designated CTQ requirements instead of applying one fixed process-validation package to every mold.

Select Process Evidence According to the Validation Question

The methods below are supporting tools, not a universal checklist. Use only the evidence needed to answer the defined process-risk or release question.

Repeated Trial Evidence Check whether selected CTQs remain consistent across controlled repeated molding runs.
Process-Window Evidence Evaluate operating margin when acceptable part quality must be shown across defined process limits.
Structured DOE Use when factor effects or interactions need to be understood for a defined engineering problem.
Capability Evidence Apply statistical analysis to designated CTQs when the measurement, sampling and release scope support it.
1. Define the Risk Identify the process-sensitive CTQ or release concern that sample inspection cannot answer alone.
2. Verify Measurement Confirm that the inspection method is suitable before process variation is interpreted.
3. Select Evidence Choose only the repeated-run, process-window, DOE or capability evidence needed for the defined question.
4. Limit the Conclusion Apply the result only to the tool, material, process and approval condition represented by the validation evidence.
Need to define or study the operating window? Continue with our scientific molding and process window validation guide for the deeper process-development methodology.
Process-validation boundary: repeated trials, DOE, cavity-pressure monitoring, process-window studies and capability analysis should be used when the engineering risk or customer validation plan justifies them. They are not universal requirements for every injection mold and do not replace drawing conformity, measurement credibility, tool-condition verification or the project-specific acceptance decision.

Validation Decision Gate

Release, Hold, or Revalidate: How Validation Evidence Supports the Decision

Validation should lead to a controlled decision about whether the current approval evidence supports the intended release condition, whether unresolved gaps require a hold, or whether a meaningful change has made part of the previous evidence no longer representative.

Release

Evidence Supports the Defined Release Scope

Release may be appropriate when the required validation evidence is complete, internally consistent and representative of the tool, material, process, inspection method and engineering revision being approved.

  • Evidence represents the current physical tool state
  • Required CTQ, functional and inspection records are available
  • Revision and sample status are aligned
  • Open deviations are formally resolved or accepted
Hold

Evidence Cannot Yet Support the Intended Release

A hold is appropriate when important evidence is missing, contradictory, unreliable or no longer aligned with the current physical tool or approved engineering condition.

  • Critical inspection evidence is incomplete or inconsistent
  • Measurement suitability is unresolved for important CTQs
  • Tool changes are not reflected in controlled engineering records
  • Approved samples do not represent the current release condition
Revalidate

Previous Evidence May No Longer Be Representative

Revalidation should be considered when a change can affect the characteristics, process condition, measurement basis or engineering state represented by the previous approval evidence.

  • Identify the change and its potential impact
  • Determine which previous evidence remains valid
  • Repeat only the affected verification where appropriate
  • Update the controlled approval basis before release
Decision principle: validation evidence supports the release decision; it does not define the project-specific acceptance limits by itself. The evidence should show whether the current condition has been evaluated against the requirements established for that program.

Why a Hold Can Be the Correct Validation Outcome

A produced sample is not enough if the approval evidence cannot be traced to the current tool and released engineering condition. Holding the tool until the evidence gap is resolved can prevent an unsupported production, shipment or transfer decision.

Revision Gap CAD, drawing, ECN, tool state or sample status does not match the evidence being used for approval.
Measurement Gap The inspection method is not yet suitable or sufficiently credible for the required CTQ decision.
Evidence Gap Required inspection, process or customer-defined approval records are incomplete.
Change Gap A relevant modification occurred after the approval evidence was generated and its impact has not yet been evaluated.
Quality engineer reviewing mold hold status deviation records CTQ evidence and controlled release documents before injection mold approval
Hold status remains controlled until the evidence gap or invalidated approval basis has been resolved.
Acceptance-criteria boundary: this section explains whether validation evidence is sufficient to support a release, hold or revalidation decision. The actual dimensional, cosmetic, fit, function and final sign-off limits belong in the project-specific injection mold acceptance criteria .

Change Control & Revalidation

Changes That Can Trigger Injection Mold Revalidation

Previous validation evidence remains applicable only while it continues to represent the approved condition. A tool, material, process, measurement, engineering or production transfer change should first trigger an impact review to determine whether existing evidence remains representative.

Trigger 01

Tooling or Insert Changes

Gate, runner, shutoff, cavity, core, cooling, insert replacement or critical steel rework can affect characteristics represented by the previous approval evidence.

When the tooling change follows confirmed hardware damage: review the mold hardware failure diagnosis first to define whether the corrective action is a local repair, redesign, refurbishment, or rebuild. That tooling decision helps determine which previous validation evidence may no longer represent the current mold condition.

Trigger 02

Resin or Material Changes

Resin-grade substitution, filler or colorant changes, recycled content, or a relevant supplier change can alter shrinkage, flow, appearance, moisture response or functional behavior.

Trigger 03

Process or Equipment Changes

Changes in press, approved molding conditions, auxiliary equipment or material preparation may require review when they can affect characteristics included in the original validation scope.

Trigger 04

Measurement-System Changes

A new fixture, gauge, CMM program, datum interpretation or inspection method can change the basis on which previous approval data was generated or compared.

Trigger 05

Drawing, ECN or Requirement Changes

A drawing revision, ECN, tolerance update, CTQ change or revised customer requirement can make part of the previous evidence no longer applicable to the current engineering condition.

Trigger 06

Press, Site or Supplier Transfer

Moving a mold to another press, production site or supplier may require additional verification when the receiving production condition can materially affect previously approved characteristics.

ECN revision records tool change history and traceability documents used to define injection mold revalidation scope
Change-impact review links the current physical tool, engineering revision and production condition to the evidence used for the previous approval.

Revalidation Does Not Automatically Mean Repeating the Full Package

The first task is to determine which previous evidence remains valid and which characteristics, cavities, process conditions or records are affected by the change. Revalidation can therefore be targeted when the change and its potential impact are sufficiently defined.

Four Questions to Define the Revalidation Scope

Before repeating dimensional inspection, process evidence, capability analysis or customer submission, determine how the change affects the original approval basis.

What Changed? Identify the exact tooling, material, process, measurement, engineering or transfer change.
What Could It Affect? Map the change to CTQs, fit, function, cavity behavior, process stability, traceability or approval documentation.
What Evidence Is Still Valid? Retain previous evidence only when it still represents the current tool, process and engineering condition.
What Needs New Evidence? Define only the affected dimensional, process, capability or customer-approval evidence that must be repeated.
Revalidation principle: the trigger is not simply that a change occurred. Revalidation depth depends on whether the change can make previously approved evidence non-representative of the current tool, material, process, measurement, engineering or transfer condition.
Need to control the change itself? Continue with our engineering change and ECN management guide for revision control, change records and implementation workflow.

Controlled Validation Records

What Belongs in an Injection Molding Validation Package?

A useful validation package should do more than collect separate reports. It should connect the released engineering data, physical tool, inspected samples, material condition, process evidence and approval status to one controlled validation condition.

Package Group 01

Engineering & Revision Records

  • Released 3D CAD and active 2D drawing revision
  • Ballooned drawing or feature-indexed inspection basis
  • CTQ identification and applicable datum references
  • ECN, drawing change and approved deviation history
Package Group 02

Tool & Trial Records

  • Current mold configuration and tool-identification records
  • T1, T2 or final run-off records relevant to the release state
  • Documented tooling corrections and closure status
  • Steel or heat-treatment records where required by the tool specification
Package Group 03

Dimensional & Inspection Evidence

  • FAI or dimensional-layout records for the agreed inspection scope
  • CMM, fixture or functional-gauge results where applicable
  • Cavity-specific results where cavity separation is relevant
  • Measurement-system evidence where required by the validation plan
Package Group 04

Material & Traceability Records

  • Approved resin grade and material-lot identification
  • COA, CoC or supplier material records where required
  • Sample-lot and cavity identification where applicable
  • Traceability links between samples, trial condition and approval record
Package Group 05

Process & Capability Evidence

  • Documented molding parameters for the evaluated condition
  • Process-window or structured trial evidence where required
  • Capability data for designated CTQs where required
  • Process qualification records where included in customer scope
Package Group 06

Approval & Release Records

  • Customer approval or agreed internal release record
  • PPAP-style submission documents where required
  • Open deviation status and approved waivers
  • Shipment, transfer or production-release status where applicable
Controlled injection molding validation package linking FAI material records trial history ECN revisions and release documents
A controlled validation package should link engineering revision, inspection evidence, material records, trial history and release status.
Package-control principle: separate reports are not enough if they cannot be traced to the same physical tool condition, drawing revision, sample set and release decision.

Four Checks Before the Validation Package Is Used for Release

Before relying on the package for production, shipment or tool-transfer approval, verify that the evidence is internally consistent.

Revision Match Drawing, ECN, tool state and inspected samples refer to the same approved condition.
Evidence Match FAI, measurement, capability and process records correspond to the intended approval scope.
Traceability Match Material, cavity, sample, trial and release records can be traced without ambiguity.
Approval Match Customer sign-off, deviations and release status clearly describe what has and has not been approved.
Package-scope boundary: not every project requires every record listed above. The final validation package should follow the agreed customer submission scope, CTQ risk, release objective and applicable quality or regulatory requirements. Formal PPAP, MSA, capability or process-qualification records should be included where required rather than assumed for every mold.

Risk-Based Validation Depth

When a Limited Validation Scope Can Be Appropriate

Validation depth should match the approval decision being made. Not every mold requires PPAP, formal MSA, capability studies, DOE or process qualification. The appropriate scope depends on customer requirements, CTQ risk, process sensitivity, release objective and any applicable quality or regulatory requirements.

Risk-based principle: limited scope does not mean weak control. The objective is to use the evidence needed to support the defined approval decision without adding unrelated validation activities that do not improve that decision.
Limited-Scope Path

Prototype, Development, or Bridge Tooling

When the objective is design learning, functional verification, pilot support or temporary tooling, the validation scope may focus on the characteristics required for that development stage rather than on full production-release evidence.

  • Clearly identified engineering revision
  • Critical fit and functional checks
  • Relevant dimensional sample review
  • Material confirmation where applicable
  • Controlled sample or stage approval status
Focused Approval Path

Tool or Sample Approval with Defined Risk

A focused validation package may be appropriate when the approval objective is limited to a defined tool or sample condition and the relevant CTQs, interfaces and tooling risks can be evaluated through controlled inspection and trial evidence.

  • Active drawing and revision control
  • FAI or defined dimensional inspection scope
  • Functional or assembly evidence where needed
  • Documented trial condition
  • Controlled approval status
Formal Validation Path

Production or Customer-Controlled Release

A deeper validation plan may be necessary when the intended release requires stronger evidence of process, measurement, traceability or production readiness under customer-defined or applicable program requirements.

  • Customer-defined PPAP or submission evidence where required
  • Measurement-system evidence where relevant to CTQs
  • Capability or process evidence for designated characteristics
  • Formal traceability and change-control requirements
  • Process qualification where defined by the validation plan
Injection molding validation path comparing limited-scope focused approval and formal production validation
Validation depth should follow the release objective and evidence needed for that decision, not the project label alone.

Five Questions Before Expanding the Validation Scope

  • What is being approved: a sample, tool, production condition, or transfer?
  • Which CTQs or functions make an incorrect release decision significant?
  • What evidence has the customer or program specifically requested?
  • Does process or measurement variation materially affect the decision?
  • Does an applicable validation plan define additional qualification evidence?

Validation Depth by Approval Objective

Approval Objective Core Evidence Focus Additional Evidence When Needed Key Boundary
Prototype / Development Review Fit, function, selected dimensions, material status and design-learning evidence. Additional dimensional, functional or process checks when the development objective calls for them. Does not by itself establish production readiness.
Tool / Sample Approval Released revision, dimensional evidence, tooling status, functional checks and controlled trial records. Measurement, repeatability, cavity comparison or process evidence when the defined risk requires it. Sample conformity does not automatically establish production capability.
Production Release Representative tool, process, inspection and approval evidence for the defined production condition. Customer-defined PPAP, capability, process-window or formal qualification evidence where required. Evidence depth follows the agreed customer and validation scope.
Tool / Site Transfer Tool condition, revision control, approved samples, trial records and controlled handover information. Receiving-condition verification or targeted revalidation when transfer conditions can affect approved characteristics. Tool shipment does not automatically establish production readiness at the receiving site.
Validation-depth boundary: a limited validation scope still requires controlled evidence, and a formal validation scope does not mean that every available quality method must be applied. The scope should be sufficient for the actual release decision and any customer, quality or regulatory requirements.
Is the tooling strategy itself still being decided? Review our rapid tooling vs production mold decision guide when prototype, bridge or production-tool intent affects the validation approach.

Validation FAQ

Injection Molding Validation FAQ

These questions clarify common boundaries between sample conformity, validation evidence, process stability, revalidation and the final customer-defined approval scope.

What is the difference between injection mold validation and mold acceptance?

Validation determines whether the tool, process, measurement basis and supporting evidence are sufficient for the defined release condition.

Mold acceptance applies the project-specific dimensional, cosmetic, functional and sign-off requirements used to decide whether that condition can be accepted, conditionally approved or held.

Is FAI enough for injection mold validation?

FAI may be sufficient for the agreed sample or tool-approval scope when broader production evidence is not required and the relevant risks can be addressed through dimensional, functional, material and controlled trial records.

FAI alone does not establish long-term process stability, measurement-system suitability or statistical capability.

Does every injection mold require PPAP?

No. PPAP is used when the customer or program defines a formal production-approval submission requirement.

The submission level and required records should follow the actual customer scope rather than being applied automatically to every injection molding project.

Is Gage R&R required before using Cpk or Ppk results?

Measurement-system suitability should be established before capability data is relied upon for an approval decision. Depending on the characteristic and customer requirements, this may include formal MSA or Gage R&R.

Formal Gage R&R is not automatically required for every dimension, but the measurement method must be appropriate for the characteristic being evaluated.

Does a successful T1 trial mean the injection mold is validated?

Not necessarily. T1 normally provides an initial engineering baseline and helps identify tooling, dimensional, filling, ejection, appearance or assembly risks.

Additional trials or evidence may still be needed to verify corrections, repeatability or the final release condition.

When is process-window validation needed in injection molding?

Additional process evidence becomes useful when sample conformity alone cannot answer whether designated CTQs remain stable under relevant production variation.

Repeated trials, process-window studies, structured DOE or capability evidence may be used when the engineering risk or customer validation plan justifies them; they are not universal requirements for every mold.

What changes can trigger injection mold revalidation?

Tooling, material, process, measurement, engineering-revision or production-transfer changes can trigger an impact review when they may make previous approval evidence no longer representative.

Revalidation should then focus on the affected evidence rather than automatically repeating the entire validation package.

Does every medical injection molding project require IQ/OQ/PQ?

No universal requirement applies to every medical molding project. IQ/OQ/PQ or similar process-qualification activities may be required when they are defined by the customer validation plan, product risk or applicable regulatory framework.

The validation and documentation scope should therefore be agreed for the specific program rather than inferred from the medical application label alone.

FAQ scope note: customer specifications, approved drawings, CTQ classifications, quality agreements, validation plans and applicable regulatory requirements take precedence over general examples in this guide.

Validation Scope Review

Send Your Mold Requirements for Validation & Tool Release Review

Share your current CAD, drawing, CTQs, resin requirements and intended release condition so our engineering team can review what should be validated, which evidence may be needed, and where tooling, measurement or documentation gaps could affect the approval path.

Review scope may include: CTQ and tolerance feasibility, tooling-condition questions, inspection method suitability, trial-stage evidence, revision-control gaps, material and traceability requirements, and FAI, PPAP-style, capability or process-validation evidence where required by the customer or program scope.

Helpful Inputs for the Review

CAD & Drawing Latest 3D CAD and released 2D drawing or current engineering revision.
CTQs & Interfaces Critical dimensions, datum strategy, functional interfaces and special characteristics.
Resin & Part Requirements Resin grade, reinforcement, appearance, functional and application requirements.
Customer Approval Requirements FAI, PPAP, capability, traceability, process qualification or other customer-defined evidence.
Release Objective Sample approval, tool release, production release, shipment, transfer or supplier handover.
Current Tool / Trial Status New tooling, T1/T2 stage, completed corrections, existing tool, ECN change or transfer condition.
Scope note: the final validation plan and release criteria remain project-specific. Customer drawings, quality agreements, applicable regulatory requirements and customer-defined approval plans take precedence. For medical programs, validation or process-qualification documentation is supported according to the agreed customer scope; clinical, sterilization and regulatory approval responsibilities remain with the applicable customer or legal manufacturer.

Defining the release objective and validation evidence before final shipment or production approval helps reduce revision mismatch, incomplete documentation and unsupported approval decisions.

Upload CAD for Validation Review